Biphenyl

Biphenyl

SCHEMBL27630230

CCCC(=O)N1CCCCC1.c1ccc(-c2ccccc2)cc1

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ NAAA Q02083 1/20 0.65
▸ NPC1 O15118 4/20 0.58
▸ TDP1 Q9NUW8 2/20 0.58
▸ ALDH1A1 P00352 4/20 0.55
▸ RAB9A P51151 4/20 0.55
▸ SMN1; SMN2 Q16637 4/20 0.55
▸ HPGD P15428 3/20 0.55
▸ LMNA P02545 2/20 0.55
▸ KMT2A Q03164 5/20 0.54
▸ MEN1 O00255 4/20 0.54
▸ L3MBTL1 Q9Y468 2/20 0.54
▸ KDM4E B2RXH2 1/20 0.54
▸ PKM P14618 1/20 0.54
▸ MAPK1 P28482 1/20 0.51
▸ GAA P10253 1/20 0.51
▸ HSD17B10 Q99714 1/20 0.51
▸ HTT P42858 1/20 0.50
▸ NPSR1 Q6W5P4 1/20 0.50
▸ POLB P06746 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Biphenyl SCHEMBL27530949 0.98 NAAA (0.67) NAAANPC1TDP1ALDH1A1RAB9A
SCHEMBL3839653 0.84 L3MBTL1 (0.73) NPC1TDP1ALDH1A1SMN1; SMN2HPGD
SCHEMBL84806 0.84 L3MBTL1 (0.73) NPC1TDP1ALDH1A1SMN1; SMN2HPGD
SCHEMBL805464 0.82 L3MBTL1 (0.72) NPC1TDP1ALDH1A1SMN1; SMN2HPGD
Hydrochloric Acid SCHEMBL28021541 0.80 L3MBTL1 (0.69) NPC1TDP1ALDH1A1SMN1; SMN2HPGD
SCHEMBL16333764 0.79 NAAA (1.00) NAAANPC1TDP1ALDH1A1RAB9A
SCHEMBL9762642 0.78 — —
SCHEMBL12282092 0.77 MAPT (0.76) NPC1ALDH1A1RAB9ASMN1; SMN2LMNA
SCHEMBL17087869 0.76 NPC1 (0.96) NAAANPC1TDP1RAB9ASMN1; SMN2
SCHEMBL6285963 0.76 NPC1 (0.96) NAAANPC1TDP1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1816524-A Selective serotonin 2A/2C receptor inverse agonists for the treatment of neurodegenerative diseases ACADIA PHARM INC (US) 2006-08-09 — — CN claimed
CN-1816524-B Selective serotonin 2A/2C receptor inverse agonists for the treatment of neurodegenerative diseases ACADIA PHARM INC 2012-06-27 — — CN disclosed
CN-1816524-A Selective serotonin 2A/2C receptor inverse agonists for the treatment of neurodegenerative diseases ACADIA PHARM INC (US) 2006-08-09 — — CN disclosed
CN-1777612-A New piperidinylamino-thieno[2,3-d] pyrimidine compounds PREDIX PHARMACEUTICALS HOLDING (US) 2006-05-24 — — CN disclosed
Send feedback